Stocks Waiting For The News
The New Delhi-based Ranbaxy Laboratories on Thursday announced that it had got approval from the US drug authorities to market a paediatric dose of its generic version of Augmentin, GlaxoSmithKline
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Mar 21 2003 | 12:00 AM IST